The Terry Fox New Frontiers Program Project Grants is a long‐standing program involving the best cancer researchers in Canada. These programs support Canadian research teams exploring new frontiers in cancer research (i.e., breakthrough and transformative biomedical, clinical and translational research which may form the basis for innovative cancer prevention, diagnosis and/or treatment).
Templates
- Letter of Intent
- Full Application
- Evaluation Criteria
Guidance provided
Summary of Letter of Intent stage
As described in the competition Request for Applications (RFA), The Terry Fox Research Institute (TFRI) has created a Program Project Grant Steering Committee on Research Excellence (PPG SCORE) which will oversee this year's competition. The committee reviewed 8 Letters of Intent (LOIs) on Wednesday August 29, 2018 in Toronto. All LOIs received were from established cancer researchers proposing to study important cancer questions in novel and innovative ways. The committee has recommended that four LOI teams be invited to prepare full applications.
Program Title
|
Project Leader(S)
|
|
Treating Seed and Soil: Finding new therapeutic vulnerabilities in tumors and their microenvironments
|
Sean Egan
|
|
Acute Leukemia Immunotherapeutic alternatiVEs (ALIVE)
|
Elie Haddad
Denis-Claude Roy
|
|
Triggers and Targets in the Tumor Microenvironment: Hypoxia and Beyond
|
Marianne Koritzinsky
Michael Milosevic
|
|
Targeting Metabolic Vulnerabilities in Cancer
|
Peter Siegel
Julie St-Pierre
|
TFRI SCORE Committee Membership
|
David Rose, PhD (chair)
|
Professor and Chair, Dept of Biology, University of Waterloo
|
|
Jennifer Chan, MD
|
Associate Professor, University of Calgary, Kids Cancer Care Foundation Chair in Pediatric Oncology, Deputy Director, Charbonneau Cancer Institute
|
|
Elizabeth Eisenhauer MD FRCPC FRSC
|
Professor Emeritus, Queen’s University
|
|
Spencer Gibson, PhD
|
Head of Cell Biology, Research Institute in Oncology and Hematology, Professor (tenured), Departments of Biochemistry and Medical Genetics and Immunology, University of Manitoba
|
|
Calum MacAulay, PhD
|
Head, and Distinguished Scientist, Imaging Unit, Integrative Oncology Department, BC Cancer Agency
|
|
Anne-Marie Mes-Masson, PhD
|
Full professor, University of Montréal, Dept. Medicine, Faculty of Medicine, Institut du cancer de Montréal, CRCHUM, University of Montréal
|
|
Lynne-Marie Postovit, PhD
|
Co-director, Basic Research, Cancer Research Institute of Northern Alberta, Alberta Innovates Health Solutions Translational Health Chair in Cancer, Sawin-Baldwin Chair in Ovarian Cancer & Dr. Anthony Noujaim Legacy Oncology Chair, Associate Professor, Department of Oncology, Associate Adjunct Professor, Department of Obstetrics and Gynecology, University of Alberta
|
|
Lillian Siu, MD FRCPC
|
BMO Chair in Precision Genomics, Professor, University of Toronto, Director of Phase I Program, Princess Margaret Cancer Centre
|
For inquiries, please contact:
Russell Watkins
Terry Fox Research Institute
675 West 10th Avenue
Vancouver, BC V5Z 1L3 Canada
Telephone: 1-604-675-8000 ext 7624
Email: rwatkins@tfri.ca